MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec
Go back to MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec| (AMEX: MKKGY) | Delayed: 31.64 -0.06 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.70 | 52 Week High | $ | |||
| Open | $31.96 | 52 Week Low | $ | |||
| Day High | $31.98 | P/E | N/A | |||
| Day Low | $31.64 | EPS | $ | |||
| Volume | 41,656 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 131.07 +0.59 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.48 | 52 Week High | $65.46 | |||
| Open | $131.44 | 52 Week Low | $47.97 | |||
| Day High | $131.71 | P/E | 89.16 | |||
| Day Low | $130.24 | EPS | $1.47 | |||
| Volume | 6,154,306 | |||||
